7 October
|
HALLS |
PEDIATRIC ONCOLOGY PROGRAM |
|||
|
07.20 - 08.10 |
ORAL PRESENTATION SESSION 4 |
|||
|
07:20 - 07.30 |
Evaluation of Microbiologically Documented Bloodstream Infections in Pediatric Hematology/Oncology Patients: Results of Ten Years |
Zehra Aslı İşeri Küskü |
|
|
|
07.30 - 07.40 |
Impact of Covid-19 Pandemıic on Delay of Childhood Cancer Dıagnosis and the Outcomes in a Pedıatric Hematology/Oncology Department |
Selma Çakmakçı(Virtual) |
|
|
|
07.40 - 07.50 |
Laboratory and Clınıcal Features of Tumor Lysıs Syndrome in Chıldren Wıth Hıgh-Grade Non-Hodgkın Lymphoma and Evaluatıon Long-Term Renal Functıons in Survıvors |
Bahar Genç |
|
|
|
07.50 - 08.00 |
Nivolumab Experıence in Pedıatric Malignities |
Melek Yaman Ortaköylü |
|
|
|
|
SESSION 6 -TREATMENT OF PEDIATRIC NONHODGKIN LYMPHOMAS |
CHAIRS: Tezer Kutluk, Nurdan Taçyıldız |
||
|
08.20 - 08.50 |
Treatment of mature B cell lymphomas |
Nilgün Kurucu |
||
|
08.50 - 09.20 |
Treatment of lymphoblastic lymphomas |
Bilgehan Yalçın |
||
|
09.20 - 09.50 |
Treatment of anaplastic large B cell lymphomas |
Dilek İnce |
||
|
09.50 - 10.20 |
General Discussion Chair: Burça Aydın |
|||
|
10:20 - 10.25 |
COFFEE BREAK |
|||
|
|
||||
|
|
SESSION 7 -TREATMENT OF PEDIATRIC RELAPSE/REFRACTORY NONHODGKIN LYMPHOMAS |
CHAIRS: Emel Ünal, Serap Aksoylar |
||
|
10.25 - 10.55 |
Treatment of relapse/refractory B cell lymphomas |
Gülşah Tanyıldız |
||
|
10.55 - 11.25 |
Treatment of relapse/refractory non-B cell lymphomas |
Derya Özyörük |
||
|
11.25 - 11.55 |
Stem cell transplantation in nonHodgkin lymphomas |
Fatih Erbey |
||
|
11.55 - 12.00 |
General Discussion Chair: Ceyhun Bozkurt |
|||
|
12.00 - 12.30 |
BREAK |
|||
|
12.30 - 13.30 |
LUNCH BREAK |
|||
|
|
||||
|
|
SESSION 8 -PEDIATRIC BRAIN TUMORS |
CHAIRS: Rejin Kebudi, Cengiz Canpolat |
||
|
13.30 - 14.00 |
Treatment management in ependymoma |
Maura Massimino |
||
|
14.00 - 14.30 |
Treatment management in high grade glial tumors |
Maura Massimino |
||
|
14.30 - 15.00 |
Stem cell transplantation in brain tumors |
Volkan Hazar |
||
|
15.00 - 15.05 |
General Discussion Chair: Gülay Sezgin |
|||
|
15.05 - 15.35 |
BREAK |
|||
|
|
SESSION 9 -PEDIATRIC HEPATIC TUMORS |
CHAIRS: Gürses Şahin, Neriman Sarı |
||
|
15.35 - 16.05 |
Treatment management in hepatoblastoma |
Deniz Tuğcu |
||
|
16.05 - 16.35 |
Treatment management in hepatocellular carcinoma |
Begül Küpeli |
||
|
16.35 - 17.05 |
Treatment management of other hepatic tumors |
Bahar Genç |
||
|
17.05 - 17.10 |
General Discussion Chair: Elif Güler |
|||
|
17.10 - 17.40 |
COFFEE BREAK |
|||
|
|
SESSION 10 - LATE SIDE EFFECTS |
CHAIRS: Melissa Hudson, Nurdan Taçyıldız |
||
|
17.40 - 18.10 |
Late side effects in nonHodgkin lymphoma |
Sonay İncesoy Özdemir |
||
|
18.10 - 18.40 |
Late side effects in brain tumors |
Melissa Hudson |
||
|
18.40 - 19.10 |
Transition from pediatric to adult follow-up care |
Melissa Hudson |
||
|
19.10 - 19.15 |
General Discussion Chair: Handan Uğur Dinçaslan |
|||
|
19.15 |
CLOSING REMARKS OF ONCOLOGY PROGRAMS |
|||